CCCC vs MAR · rev $35.6M vs P/E 32, rev $26.19B
C4 Therapeutics Inc (CCCC) versus Marriott International Inc (MAR) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Marriott International Inc (MAR) is a lodging company listed on US.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported MAR revenue for 2025-12-31 was $26.19B. Net income was $2.60B. Revenue was up 4.3% from 2024-12-31 to 2025-12-31. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
CCCC currently screens at market cap $425.7M. MAR currently screens at market cap $76.70B and trailing P/E 31.9.
Not investment advice. Open the CCCC and MAR stock pages for the full models.
Not investment advice.